Vietnam is significantly expanding its cancer treatment capacity as rising cancer incidence and growing investment in oncology infrastructure drive demand for advanced radiotherapy technologies. Hospitals across the country are upgrading radiation oncology services with next-generation treatment systems that improve precision, shorten treatment times and enhance patient outcomes.
While a standalone market value for Vietnam's radiotherapy sector is not widely published, industry analysis estimates the country's radiotherapy market is currently worth US$60–80 million in 2025 and is projected to reach US$95–125 million by 2030. This growth is expected to outpace the global market as Vietnam continues to expand access to modern cancer treatment and replace ageing radiotherapy equipment.
The market is underpinned by the rapid growth of Vietnam's broader oncology sector. According to IMARC Group, the country's cancer diagnostics market reached US$887.2 million in 2025 and is forecast to grow to US$1.60 billion by 2034, reflecting increasing demand for comprehensive cancer diagnosis and treatment services.
Several long-term trends are accelerating investment in radiotherapy across Vietnam:
- Rising incidence of breast, lung, liver, colorectal and cervical cancers.
- Government investment in modernising cancer hospitals and expanding regional oncology centres.
- Installation of advanced linear accelerators (LINACs) and image-guided radiotherapy systems.
- Growing adoption of precision radiotherapy techniques, including Intensity-Modulated Radiotherapy (IMRT), Image-Guided Radiotherapy (IGRT), Volumetric Modulated Arc Therapy (VMAT) and Stereotactic Body Radiotherapy (SBRT).
- Increasing use of artificial intelligence to support treatment planning, image guidance and adaptive radiotherapy.
- Expansion of private oncology centres and specialist cancer treatment facilities.
Radiotherapy remains one of the most effective cancer treatments available, with international studies indicating that around 50% of cancer patients require radiotherapy at some stage during their treatment. Advances in image guidance, motion management and AI-assisted planning are enabling clinicians to deliver radiation with greater precision while minimising exposure to healthy tissue.
Vietnam's radiotherapy market is also supported by continued investment in diagnostic imaging. The country's medical imaging market is expanding as hospitals adopt more advanced MRI, CT and PET technologies that play a critical role in radiotherapy planning and treatment verification. In parallel, Vietnam's clinical diagnostics market is forecast to reach US$773.4 million by 2034, reflecting broader investment in modern healthcare infrastructure and advanced diagnostic capabilities.
Leading global suppliers including Varian (Siemens Healthineers), Elekta, Accuray, GE HealthCare, Philips Healthcare, Canon Medical Systems, RaySearch Laboratories and IBA continue to introduce innovations such as AI-enabled treatment planning, adaptive radiotherapy, MRI-guided treatment systems and next-generation quality assurance technologies, helping improve both clinical outcomes and operational efficiency.
As Vietnam continues to strengthen its national cancer strategy and expand access to advanced oncology services, radiotherapy is expected to play an increasingly important role in improving survival rates and patient care. For manufacturers of radiation therapy equipment, treatment planning software, medical imaging systems and oncology technologies, Vietnam represents one of Southeast Asia's most promising long-term growth markets.